Assessment of the Antiviral Effect of Atorvastatin on Hepatitis C Virus
NCT00403533
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis C
Interventions
DRUG:
20 mg of atorvastatin daily
Sponsor
Massachusetts General Hospital